Patent · US Active

Ionic liquids for internal delivery

US11446253B2 · kind B2 · utility

6Cited by
1References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 16, 2018
Grant dateSep 20, 2022
Priority date
Expiry dateNov 16, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/4891
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The technology described herein is directed to compositions comprising CAGE and at least one active compound, e.g., for oral or parenteral administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.